Skip to content

Role of transcranial direct current stimulation for treating obsessive compulsive symptoms in Schizophrenia

Efficacy of Transcranial direct current stimulation in treatment of obsessive compulsive symptoms in Schizophrenia

Status
Active, not recruiting
Phases
Phase 4
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2020/03/024007
Enrollment
30
Registered
2020-03-16
Start date
Unknown
Completion date
Unknown
Last updated
2021-11-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: F20- Schizophrenia

Interventions

Intervention1: Active TDCS group: 2 mA of current stimulation for 30 mins. total of 10 sessions ( 2 sessions per day for 5 days) Control Intervention1: Sham control group: Active current for the first

Sponsors

Schizophrenia Reserach Foundation
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: Schizophrenia Patients (ICD -10 Diagnosis ) aged 18-50 years Moderate to severe rating on YBOCS (score of 15 >) Consenting for the study. No change in medications or other add on treatments during the study period.

Exclusion criteria

Exclusion criteria: • Patient who have undergone tDCS treatment in the last 3 months. • Patients with mental retardation, H/O drug or alcohol dependence, epilepsy and pregnant women. • Patient receiving ECT. • Existence of serious medical/neurological disorder. • Patients who are uncooperative due to the severity of the illness. • Not consenting to participate in the study.

Design outcomes

Primary

MeasureTime frame
Improvement in YBOCS(Yale brown obsessive compulsive scale ) score compared to baseline after 5 days (10 sessions / 2 sessions per day) and 1 month of intervention.Timepoint: Baseline After 5 days of treatment and After 1 month post treatment

Secondary

MeasureTime frame
Improvement in YBOCS ratings and overall functioning scores using SOFAS (social and occupational functioning) & CGI ( Clinical global impression) at 1 month compared to preintervention scoring.Timepoint: 1 month

Countries

India

Contacts

Public ContactHema Tharoor

Schizophrenia Research Foundation

hematharoor@scarfindia.org04426151073

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026